These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 23079519)

  • 21. Synthesis and biological evaluation of 3-aminopyrrolidine derivatives as CC chemokine receptor 2 antagonists.
    Lim JW; Oh Y; Kim JH; Oak MH; Na Y; Lee JO; Lee SW; Cho H; Park WK; Choi G; Kang J
    Bioorg Med Chem Lett; 2010 Apr; 20(7):2099-102. PubMed ID: 20223662
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis of 3-phenylsulfonylmethyl cyclohexylaminobenzamide-derived antagonists of CC chemokine receptor 2 (CCR2).
    Yang MG; Xiao Z; Shi Q; Cherney RJ; Tebben AJ; De Lucca GV; Santella JB; Mo R; Cvijic ME; Zhao Q; Barrish JC; Carter PH
    Bioorg Med Chem Lett; 2012 Feb; 22(3):1384-7. PubMed ID: 22225639
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Copper-mediated N-cyclopropylation of azoles, amides, and sulfonamides by cyclopropylboronic acid.
    Bénard S; Neuville L; Zhu J
    J Org Chem; 2008 Aug; 73(16):6441-4. PubMed ID: 18610980
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 4-Azetidinyl-1-heteroatom linked cyclohexane antagonists of CCR2: patent evaluation.
    Horuk R; Guilford W
    Expert Opin Ther Pat; 2011 Aug; 21(8):1275-80. PubMed ID: 21554155
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potent heteroarylpiperidine and carboxyphenylpiperidine 1-alkyl-cyclopentane carboxamide CCR2 antagonists.
    Pasternak A; Goble SD; Vicario PP; Di Salvo J; Ayala JM; Struthers M; DeMartino JA; Mills SG; Yang L
    Bioorg Med Chem Lett; 2008 Feb; 18(3):994-8. PubMed ID: 18164199
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The optimization of pyridazinone series of glucan synthase inhibitors.
    Kuang R; Wu H; Ting PC; Aslanian RG; Cao J; Kim DW; Lee JF; Schwerdt J; Zhou G; Herr RJ; Zych AJ; Yang J; Lam SQ; Jenkins DM; Sakwa SA; Wainhaus S; Black TA; Cacciapuoti A; McNicholas PM; Xu Y; Walker SS
    Bioorg Med Chem Lett; 2012 Aug; 22(16):5268-71. PubMed ID: 22818082
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Indole-3-piperazinyl derivatives: novel chemical class of 5-HT(6) receptor antagonists.
    Nirogi RV; Deshpande AD; Kambhampati R; Badange RK; Kota L; Daulatabad AV; Shinde AK; Ahmad I; Kandikere V; Jayarajan P; Dubey PK
    Bioorg Med Chem Lett; 2011 Jan; 21(1):346-9. PubMed ID: 21134749
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-based rational design, synthesis and antifungal activity of oxime-containing azole derivatives.
    Xu Y; Sheng C; Wang W; Che X; Cao Y; Dong G; Wang S; Ji H; Miao Z; Yao J; Zhang W
    Bioorg Med Chem Lett; 2010 May; 20(9):2942-5. PubMed ID: 20362444
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lead optimisation of the N1 substituent of a novel series of indazole arylsulfonamides as CCR4 antagonists and identification of a candidate for clinical investigation.
    Procopiou PA; Ford AJ; Graves RH; Hall DA; Hodgson ST; Lacroix YM; Needham D; Slack RJ
    Bioorg Med Chem Lett; 2012 Apr; 22(8):2730-3. PubMed ID: 22437117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Carboxylic acid bioisosteres acylsulfonamides, acylsulfamides, and sulfonylureas as novel antagonists of the CXCR2 receptor.
    Winters MP; Crysler C; Subasinghe N; Ryan D; Leong L; Zhao S; Donatelli R; Yurkow E; Mazzulla M; Boczon L; Manthey CL; Molloy C; Raymond H; Murray L; McAlonan L; Tomczuk B
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1926-30. PubMed ID: 18308567
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Design and synthesis of novel CCR2 antagonists: investigation of non-aryl/heteroaryl binding motifs.
    Trujillo JI; Huang W; Hughes RO; Rogier DJ; Turner SR; Devraj R; Morton PA; Xue CB; Chao G; Covington MB; Newton RC; Metcalf B
    Bioorg Med Chem Lett; 2011 Mar; 21(6):1827-31. PubMed ID: 21316220
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potent antagonists of the CCR2b receptor. Part 3: SAR of the (R)-3-aminopyrrolidine series.
    Moree WJ; Kataoka K; Ramirez-Weinhouse MM; Shiota T; Imai M; Tsutsumi T; Sudo M; Endo N; Muroga Y; Hada T; Fanning D; Saunders J; Kato Y; Myers PL; Tarby CM
    Bioorg Med Chem Lett; 2008 Mar; 18(6):1869-73. PubMed ID: 18313297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N,N-Dimethyl-[9-(arylsulfonyl)-2,3,4,9-tetrahydro-1H-carbazol-3-yl]amines as novel, potent and selective 5-HT₆ receptor antagonists.
    Nirogi RV; Konda JB; Kambhampati R; Shinde A; Bandyala TR; Gudla P; Kandukuri KK; Jayarajan P; Kandikere V; Dubey PK
    Bioorg Med Chem Lett; 2012 Nov; 22(22):6980-5. PubMed ID: 23036955
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of CXCR3 antagonists. Part 2: Identification of 2-amino(4-piperidinyl)azoles as potent CXCR3 antagonists.
    Watson RJ; Allen DR; Birch HL; Chapman GA; Hannah DR; Knight RL; Meissner JW; Owen DA; Thomas EJ
    Bioorg Med Chem Lett; 2007 Dec; 17(24):6806-10. PubMed ID: 17964154
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quinazolinedione sulfonamides: a novel class of competitive AMPA receptor antagonists with oral activity.
    Koller M; Lingenhoehl K; Schmutz M; Vranesic IT; Kallen J; Auberson YP; Carcache DA; Mattes H; Ofner S; Orain D; Urwyler S
    Bioorg Med Chem Lett; 2011 Jun; 21(11):3358-61. PubMed ID: 21531559
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel progesterone receptor modulators: 4-aryl-phenylsulfonamides.
    McComas C; Cohen J; Huselton C; Marella M; Melenski E; Mugford C; Slayden O; Winneker R; Wrobel J; Yudt MR; Fensome A
    Bioorg Med Chem Lett; 2012 Dec; 22(23):7119-22. PubMed ID: 23079530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of chemokine receptor function on monocytes in whole blood: In vitro and ex vivo evaluations of a CCR2 antagonist.
    Wisniewski T; Bayne E; Flanagan J; Shao Q; Wnek R; Matheravidathu S; Fischer P; Forrest MJ; Peterson L; Song X; Yang L; Demartino JA; Struthers M
    J Immunol Methods; 2010 Jan; 352(1-2):101-10. PubMed ID: 19913021
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Capped diaminopropionamide-glycine dipeptides are inhibitors of CC chemokine receptor 2 (CCR2).
    Carter PH; Brown GD; Friedrich SR; Cherney RJ; Tebben AJ; Lo YC; Yang G; Jezak H; Solomon KA; Scherle PA; Decicco CP
    Bioorg Med Chem Lett; 2007 Oct; 17(19):5455-61. PubMed ID: 17720492
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and structure-activity relationship of 7-azaindole piperidine derivatives as CCR2 antagonists.
    Xia M; Hou C; DeMong D; Pollack S; Pan M; Singer M; Matheis M; Murray W; Cavender D; Wachter M
    Bioorg Med Chem Lett; 2008 Dec; 18(24):6468-70. PubMed ID: 18990568
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and evaluation of cis-3,4-disubstituted piperidines as potent CC chemokine receptor 2 (CCR2) antagonists.
    Cherney RJ; Nelson DJ; Lo YC; Yang G; Scherle PA; Jezak H; Solomon KA; Carter PH; Decicco CP
    Bioorg Med Chem Lett; 2008 Sep; 18(18):5063-5. PubMed ID: 18722120
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.